IL4 and asthma: In murine models of allergen-induced asthma, blockade of either IL-4 or its receptor has been shown to inhibit eosinophil influx into the airways and IL-5 release from T cells, as well as decreasing lung inflammation, serum IgE levels, and airway hyperresponsiveness to methacholine [70, 71].